AF
ALT icon

Amalgamated Financial’s Altimmune ALT Stock Holding History

Amalgamated Financial’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$29K Buy
+4,793
New +$35.3K ﹤0.01% 2634

Other funds holding ALT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Amalgamated Financial's ALT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Altimmune (ALT) in Q1 2022: 4,793 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #2634 among its holdings.

103 funds tracked by Wall St. Rank hold ALT as of Q1 2022.

  • Amalgamated Financial held 4,793 shares of Altimmune worth $29K as of Q1 2022.
  • Altimmune was a new Amalgamated Financial position in Q1 2022.
  • Altimmune made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2634 holding.
  • 103 funds tracked by Wall St. Rank held Altimmune as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.